Concomitant 1q+ and t(4;14) influences disease characteristics, immune system, and prognosis in double-hit multiple myeloma

Blood Cancer J. 2023 Nov 10;13(1):167. doi: 10.1038/s41408-023-00943-2.

Authors

Michael Ozga¹, Qiuhong Zhao¹, Laila Huric¹, Cecelia Miller², Ashley Rosko¹, Abdullah Khan¹, Elvira Umyarova¹, Don Benson¹, Francesca Cottini³

Affiliations

¹ The Ohio State University Comprehensive Cancer Center, Department of Internal Medicine, Division of Hematology, Columbus, OH, USA.
² The Ohio State University Comprehensive Cancer Center, Department of Pathology, Columbus, OH, USA.
³ The Ohio State University Comprehensive Cancer Center, Department of Internal Medicine, Division of Hematology, Columbus, OH, USA. Francesca.cottini@osumc.edu.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Chromosome Aberrations
Humans
Immune System
Multiple Myeloma* / diagnosis
Multiple Myeloma* / genetics
Prognosis

Grants and funding

K08 CA263476/CA/NCI NIH HHS/United States